These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9403092)

  • 21. Gender-specific effects in the treatment of acute schizophrenia with risperidone.
    Raedler TJ; Schreiner A; Naber D; Wiedemann K
    Pharmacopsychiatry; 2006 Sep; 39(5):171-4. PubMed ID: 16944407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A; Okamura T
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):556-62. PubMed ID: 16194258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
    Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Schizophrenia and quality of life--new definition of therapeutic targets].
    Fortschr Neurol Psychiatr; 1997 Nov; 65(11 Suppl Schizophre):1-4. PubMed ID: 9431352
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone in disorganised schizophrenia.
    Bleich S; Degner D; Kropp S; Hajak G; Rüther E
    Aust N Z J Psychiatry; 2000 Jun; 34(3):534-5. PubMed ID: 10881990
    [No Abstract]   [Full Text] [Related]  

  • 27. Risperidone and sulpiride: Brands vs generics.
    Andrade C
    Schizophr Res; 2018 Mar; 193():486. PubMed ID: 28821357
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic use of neuroleptics. Satellite symposium "Risperdal: new horizons for the schizophrenic patient". 9th World Congress for Psychiatry, Rio de Janeiro, 6-12 June 1993].
    Nervenarzt; 1993 Nov; 64(11 Suppl):1-8. PubMed ID: 7477597
    [No Abstract]   [Full Text] [Related]  

  • 29. What is the right pharmacotherapy for alcohol use disorder in patients with schizophrenia?
    Batki SL
    J Clin Psychiatry; 2015 Oct; 76(10):e1336-7. PubMed ID: 26528663
    [No Abstract]   [Full Text] [Related]  

  • 30. How to best treat patients with schizophrenia and co-occurring alcohol use disorder.
    Petrakis IL
    J Clin Psychiatry; 2015 Oct; 76(10):e1338-9. PubMed ID: 26528664
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic Inflammation Complicates the Interpretation of Therapeutic Drug Monitoring of Risperidone.
    Helland A; Habib S; Ulvestad L; Spigset O
    J Clin Psychopharmacol; 2018 Jun; 38(3):263-265. PubMed ID: 29613864
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple visits for abdominal pain, constipation, and "I need a test for sexually transmitted diseases".
    Rohr-Kirchgraber T
    Adolesc Med State Art Rev; 2012 Aug; 23(2):313-8. PubMed ID: 23162938
    [No Abstract]   [Full Text] [Related]  

  • 33. Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia.
    Dourish CT; Dawson GR
    Biomark Med; 2014; 8(1):5-8. PubMed ID: 24325219
    [No Abstract]   [Full Text] [Related]  

  • 34. Risperidone for treatment of childhood schizophrenia.
    Sourander A
    Am J Psychiatry; 1997 Oct; 154(10):1476. PubMed ID: 9326842
    [No Abstract]   [Full Text] [Related]  

  • 35. [Promising effects of the new antipsychotic agents in schizophrenia. But recommendations of the Medical Products Agency are conservative].
    Sedvall GC
    Lakartidningen; 1997 May; 94(20):1873-6. PubMed ID: 9190476
    [No Abstract]   [Full Text] [Related]  

  • 36. Further clinical experience with oxyprothepin-decanoate.
    Kalvach Z; Hálková E; Bastecký J
    Act Nerv Super (Praha); 1981 Dec; 23(4):271-2. PubMed ID: 6121440
    [No Abstract]   [Full Text] [Related]  

  • 37. Risperidone and related 5HT2/D2 antagonists: a new type of antipsychotic agent?
    Megens AA; Kennis LE
    Prog Med Chem; 1996; 33():185-232. PubMed ID: 8776944
    [No Abstract]   [Full Text] [Related]  

  • 38. Stuttering improved with risperidone.
    van Wattum PJ
    J Am Acad Child Adolesc Psychiatry; 2006 Feb; 45(2):133. PubMed ID: 16429082
    [No Abstract]   [Full Text] [Related]  

  • 39. Schizophrenia in the 21st century: new insights and translation into improved therapies.
    Pratt J
    J Psychopharmacol; 2015 Feb; 29(2):83-4. PubMed ID: 25650373
    [No Abstract]   [Full Text] [Related]  

  • 40. [3 years of clinical experience with risperidone: new therapeutic standards in the management of schizophrenia].
    Nervenarzt; 1996 Oct; 67(10 Suppl Neue Thera):1-4. PubMed ID: 9403092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.